Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 108 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $272,924 | +124.5% | 40,195 | +65.7% | 0.00% | – |
| Q1 2023 | $121,568 | -62.6% | 24,265 | -63.6% | 0.00% | – |
| Q4 2022 | $325,257 | +82.7% | 66,651 | +438.6% | 0.00% | – |
| Q3 2022 | $178,000 | -75.4% | 12,375 | -72.3% | 0.00% | – |
| Q4 2021 | $724,000 | +38.4% | 44,673 | +144.0% | 0.00% | – |
| Q3 2021 | $523,000 | +139.9% | 18,311 | +154.2% | 0.00% | – |
| Q1 2021 | $218,000 | -78.6% | 7,204 | -65.0% | 0.00% | -100.0% |
| Q4 2020 | $1,020,000 | +200.0% | 20,607 | +132.5% | 0.00% | – |
| Q3 2020 | $340,000 | +10.0% | 8,864 | +23.9% | 0.00% | – |
| Q2 2020 | $309,000 | – | 7,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,104,278 | $55,890,000 | 4.98% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,587,566 | $42,166,000 | 0.81% |
| DC Investments Management, LLC | 25,000 | $664,000 | 0.45% |
| Monashee Investment Management LLC | 67,800 | $1,801,000 | 0.38% |
| Avoro Capital Advisors LLC | 310,000 | $8,234,000 | 0.38% |
| Cormorant Asset Management, LP | 200,000 | $5,312,000 | 0.34% |
| PURA VIDA INVESTMENTS, LLC | 22,350 | $594,000 | 0.12% |
| Artal Group S.A. | 150,000 | $3,984,000 | 0.10% |
| OXFORD ASSET MANAGEMENT LLP | 59,122 | $1,556,000 | 0.03% |
| Point72 Hong Kong Ltd | 3,252 | $86,000 | 0.03% |